Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

High-risk human papillomaviruses (HPVs) cause essentially all cervical cancers, most anal
and oropharyngeal cancers, and some vaginal, vulvar, and penile cancers. Improved …

Human papillomavirus (HPV)-related screening technologies and HPV vaccination offer
enormous potential for cancer prevention, notably prevention of cervical cancer. The …

Objective We assessed the age-related prevalence of high risk human papillomavirus (HR-
HPV) genotypes and the genotype-associated risk for high-grade cervical intraepithelial …

Background: Human papillomavirus (HPV) testing provides a much more sensitive method
of detection for high-grade lesions than cytology, but specificity is low. Here, we explore the …

Objectives The objective of the present study is to assess the performance of a high-risk
human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a …

Human papillomaviruses (HPVs) are the necessary cause of most cervical cancers, a large
proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The …

Objective Nine-valent human papillomavirus (9vHPV) vaccine efficacy against disease and
cervical surgeries related to all nine vaccine components was assessed compared with a …